There has been some strong media and patient outrage in the UK over a decision to not make available Bayer's Nexavar, a drug for terminally-ill liver cancer patients, through the National Health Service. UK's National Institute for Health and Clinical Excellence - referred to as the NHS' drug rationing body by the UK media - … Continue reading NICE, Nexavar, and why it matters
Apothecurry 